SEC Filing Update: #KYTX Kyverna Therapeutics, Inc. : $8.20
Sector: Others | YTD: π½ -6.18%
The SEC disclosed Today (14-AUG-2026) that Bain Capital Life Sciences Opportunities III, LP has DECREASED #KYTX Shares by -7.23% π΄
* Previous Holdings: 3.11M Shares
* Current Holdings: 2.88M Shares
* Decrease -225.00K
* Decreased (%)-7.23%
* Ownership: 4.75%
https://www.thinksabio.com/reports/isr/KYTXInstitutional ownership in #KYTX has been steadily rising over the past 3 quarters in Shares:
Q3 2025: 22.70M
Q4 2025: 34.15M
Q1 2026: 34.82M
π Institutional activity in the last 30 days for #KYTX:
β’ BLACKROCK INC β Increased holdings by 2,226,679 shares (29-JUL-2026)